Ellen M Ginzler Selected Research

Ellen M Ginzler Research Topics

Disease

31	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2002
13	Lupus Nephritis 11/2022 - 12/2004
5	Infections 01/2021 - 02/2012
3	Neoplasms (Cancer) 12/2021 - 10/2012
3	Proteinuria 01/2016 - 01/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2013 - 12/2004
2	Headache (Headaches) 12/2021 - 11/2013
2	Rheumatoid Arthritis 12/2021 - 01/2019
2	Pneumonia (Pneumonitis) 01/2021 - 02/2012
2	Body Weight (Weight, Body) 01/2021 - 11/2011
2	Hypertension (High Blood Pressure) 01/2019 - 09/2015
2	Nephritis 01/2016 - 02/2010
1	Cardiotoxicity 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Cutaneous Lupus Erythematosus 12/2021
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Toxic Optic Neuropathy 01/2021
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Multiple Sclerosis 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Cognitive Dysfunction 01/2019
1	Pre-Eclampsia (Preeclampsia) 01/2019
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2018
1	Transient Ischemic Attack 10/2018
1	Stroke (Strokes) 10/2018
1	Mood Disorders (Mood Disorder) 07/2015
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2014
1	Lymphoma (Lymphomas) 01/2014
1	Atherosclerosis 02/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2010
1	Mixed Connective Tissue Disease (MCTD) 08/2007
1	Inflammation (Inflammations) 12/2004
1	Hirsutism 09/2004
1	Stomatitis 09/2004
1	Clinical Deterioration 09/2004
1	Acne Vulgaris 09/2004

Drug/Important Bio-Agent (IBA)

10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 09/2004
10	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 11/2005
9	belimumabIBA 11/2022 - 01/2008
7	AutoantibodiesIBA 01/2019 - 11/2012
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2002
5	GlucocorticoidsIBA 12/2021 - 04/2005
4	B-Cell Activating FactorIBA 11/2022 - 01/2008
4	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
4	Estrogens (Estrogen)FDA Link 11/2012 - 09/2009
4	Dehydroepiandrosterone (DHEA)IBA 08/2008 - 07/2002
3	Monoclonal AntibodiesIBA 11/2022 - 01/2008
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2021
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 10/2005
3	SteroidsIBA 09/2015 - 07/2002
3	Azathioprine (Imuran)FDA LinkGeneric 01/2014 - 07/2008
3	CreatinineIBA 11/2011 - 12/2004
2	Antinuclear AntibodiesIBA 01/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 02/2012
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2013 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 02/2010 - 09/2009
2	Prednisone (Sone)FDA LinkGeneric 01/2010 - 07/2002
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 12/2004
2	Biological ProductsIBA 09/2009 - 01/2008
1	Chloroquine (Aralen)FDA LinkGeneric 12/2021
1	Calcineurin InhibitorsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	voclosporinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Cytidine Monophosphate (CMP)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	BC1 RNAIBA 01/2019
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	AMG623 peptibodyIBA 08/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2014
1	TACI receptor-IgG Fc fragment fusion proteinIBA 02/2012
1	AdiponectinIBA 02/2010
1	Protein CIBA 02/2010
1	Endothelial Protein C ReceptorIBA 02/2010
1	Gm(m)IBA 01/2010
1	Complement Factor B (Factor B)IBA 01/2008
1	Waste Products (Waste Product)IBA 12/2004
1	AntibodiesIBA 12/2004

Therapy/Procedure

22	Therapeutics 11/2022 - 09/2004
1	Contraindications 01/2019
1	Time-to-Treatment 11/2011
1	Remission Induction 07/2008